By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Evotec today said that it has teamed up with PsychoGenics to offer pharmaceutical and biotech companies CNS drug discovery services.

The firms will offer clients access to their complementary drug discovery platforms for identifying and developing new therapeutics for central nervous system disorders. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.